In the randomized controlled trial of NeuroAiD versus placebo following ischemic stroke, there was a trend for sex influencing the treatment effect of NeuroAiD in improving functional outcome following ischemic stroke (p=0.075).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jocn.2016.04.013 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!